Gujarat Kidney And Super Speciality Limited — Board Meeting, 28-05-2026: Outcome of Board Meeting

The Board has approved the consolidated financial results for the quarter and year ended March 31, 2026. The appointment of the CEO was deferred. The company will conduct a postal ballot for shareholders regarding changes to IPO objects. Appointments for Internal and Secretarial Auditors were also finalized.